The protective effects of urocortin1 against intracerebral hemorrhage by activating JNK1/2 and p38 phosphorylation and further increasing VEGF via corticotropin-releasing factor receptor 2

Neuroscience Letters

Volumn 589, Issue , 2015, Pages 31-36

  Xu, Shu ^a   Wu, QiuYi ^a   Guo, Gang ^a   Ding, XinSheng ^b  

^a Suzhou Medical College of Soochow University   (China)

^b THE AFFILIATED BENQ HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CRFR2; Intracerebral hemorrhage; Urocortin1; VEGF

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 9; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; UROCORTIN I; VASCULOTROPIN; ANTI-INFLAMMATORY AGENTS; CRF RECEPTOR TYPE 2; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN TISSUE; BRAIN WATER; CELL METABOLISM; CEREBELLUM; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; LATERAL BRAIN VENTRICLE; MALE; MODIFIED NEUROLOGICAL SEVERITY SCORE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING; ANIMALS; CELL LINE, TUMOR; CEREBRAL HEMORRHAGE; ENZYME ACTIVATION; HUMANS; METABOLISM; MICE; PATHOLOGY; PHOSPHORYLATION; PHYSIOPATHOLOGY; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN EDEMA; CELL LINE, TUMOR; CEREBRAL HEMORRHAGE; ENZYME ACTIVATION; HUMANS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; UROCORTINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921291476     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.01.015     Document Type: Article

References (33)

1. Adeoye O., Broderick J.P. Advances in the management of intracerebral hemorrhage, nature reviews. Neurology 2010, 6:593-601.
2. Bruijnzeel A.W., Gold M.S. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence, Brain research. Brain Res. Rev. 2005, 49:505-528.
3. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
4. Chu K., Jeong S.W., Jung K.H., Han S.Y., Lee S.T., Kim M., Roh J.K. Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J. Cerebr. Blood F. Met. 2004, 24:926-933.
5. Fujimoto S., Katsuki H., Ohnishi M., Takagi M., Kume T., Akaike A. Thrombin induces striatal neurotoxicity depending on mitogen-activated protein kinase pathways in vivo. Neuroscience 2007, 144:694-701.
6. Gravanis A., Margioris A.N. The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. Curr. Med. Chem. 2005, 12:1503-1512.
7. Grigoriadis D.E., Lovenberg T.W., Chalmers D.T., Liaw C., De Souze E.B. Characterization of corticotropin-releasing factor receptor subtypes. Ann. N. Y. Acad. Sci. 1996, 780:60-80.
8. Hanggi D., Steiger H.J. Spontaneous intracerebral haemorrhage in adults: a literature overview. Acta Neurochir. 2008, 150:371-379. discussion 379.
9. Hankey G.J., Hon C. Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke 1997, 28:2126-2132.
10. Hoff J.T., Xi G. Brain edema from intracerebral hemorrhage. Acta Neurochir. Suppl. 2003, 86:11-15.
11. Kastin A.J., Akerstrom V. Glucose and insulin increase the transport of leptin through the blood-brain barrier in normal mice but not in streptozotocin-diabetic mice. Neuroendocrinology 2001, 73:237-242.
12. Kokkotou E., et al. Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J. Immunol. 2006, 177:3355-3361.
13. Liew H.K., Hsu C.W., Wang M.J., Kuo J.S., Li T.Y., Peng H.F., Wang J.Y., Pang C.Y. Therapeutic benefit of urocortin in rats with intracerebral hemorrhage. J. Neurosurg. 2012, 116:193-200.
14. Liew H.K., Pang C.Y., Hsu C.W., Wang M.J., Li T.Y., Peng H.F., Kuo J.S., Wang J.Y. Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats. J. Neuroinflamm. 2012, 9:13.
15. MacLellan C.L., Silasi G., Poon C.C., Edmundson C.L., Buist R., Peeling J., Colbourne F. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J. Cerebr. Blood Flow Metab. 2008, 28:516-525.
16. Markovic D., Punn A., Lehnert H., Grammatopoulos D.K. Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades. Mol. Endocrinol. 2008, 22:689-706.
17. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., Fukuyama H., Nagata S., Kishimoto T. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5405-5410.
18. Ohnishi M., Katsuki H., Fujimoto S., Takagi M., Kume T., Akaike A. Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp. Neurol. 2007, 206:43-52.
19. Pagès G.B.E., Milanini J., Levy A.P., Pouysségur J. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J. Biol. Chem. 2000, 26:484-26491. 275.
20. Pan W., Akerstrom V., Zhang J., Pejovic V., Kastin A.J. Modulation of feeding-related peptide/protein signals by the blood-brain barrier. J. Neurochem. 2004, 90:455-461.
21. Peng Z.R., Yang A.L., Yang Q.D. The effect of hyperbaric oxygen on intracephalic angiogenesis in rats with intracerebral hemorrhage. J. Neurol. Sci. 2014, 342:114-123.
22. Rincon F., Mayer S.A. Novel therapies for intracerebral hemorrhage. Curr. Opin. Crit. Care 2004, 10:94-100.
23. Rosenberg G.A., Mun-Bryce S., Wesley M., Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990, 21:801-807.
24. Tezval H., Jurk S., Atschekzei F., Serth J., Kuczyk M.A., Merseburger A.S. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways. Prostate 2009, 69:443-448.
25. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
26. van L.M., Asch C.J., Rinkel G.J., van der Tweel I., Algra A., Klijn C.J. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010, 9:167-176.
27. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
28. Wan S., Zhan R., Zheng S., Hua Y., Xi G. Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron. Neurosci. Res. 2009, 63:100-105.
29. Wang J., Xu Y., Zhu H., Zhang R., Zhang G., Li S. Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2. Cancer Invest. 2008, 26:359-368.
30. Wang MJ1 L.S., Kuo J.S., Huang H.Y., Tzeng S.F., Liao C.H., Chen D.C., Chen W.F. Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation. J. Immunol. 2007, 179:6204-6214.
31. Wang X.T., Pei D.S., Xu J., Guan Q.H., Sun Y.F., Liu X.M., Zhang G.Y. Opposing effects of bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell. Signalling 2007, 19:1844-1856.
32. Xue D.B.M.M. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci. Lett. 2000, 283:230-232.
33. Zhou H.J., Tang T., Cui H.J., Yang A.L., Luo J.K., Lin Y., Yang Q.D., Li X.Q. Thrombin-triggered angiogenesis in rat brains following experimental intracerebral hemorrhage. J. Neurosurg. 2012, 117:920-928.